AR010932A1 - Derivados de la piperazina, un procedimiento para prepararlos, el empleo de los mismos en la elaboracion de medicamentos, las preparaciones farmaceuticasque los contienen y un procedimiento para elaborar estas preparaciones farmaceuticas. - Google Patents
Derivados de la piperazina, un procedimiento para prepararlos, el empleo de los mismos en la elaboracion de medicamentos, las preparaciones farmaceuticasque los contienen y un procedimiento para elaborar estas preparaciones farmaceuticas.Info
- Publication number
- AR010932A1 AR010932A1 ARP980103491A ARP980103491A AR010932A1 AR 010932 A1 AR010932 A1 AR 010932A1 AR P980103491 A ARP980103491 A AR P980103491A AR P980103491 A ARP980103491 A AR P980103491A AR 010932 A1 AR010932 A1 AR 010932A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical preparations
- procedure
- atoms
- medicines
- ch2nha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
El invento se refiere a los derivados de la piperazina de formula I, en donde R1 representa un resto de indol-3-ilo no sustituido o mono o disustituidocon Hal, CN, A, AO, OH, CONH2, CONHA, CONA2, COOH, COOA, CH2OH, CH2OA, CH2NH, CH2NHA y/oCH2NA 2, R2 representa 2-oxo-2H-1-benzopiran-6-ilo o 2-oxo-2H-1-benzopiran-4-ilo no sustituido o mono o disustituido con A, AO, OH, Hal, CN, NO2, NH2, NHA, NA2, COA, CONH2, CONHA, CONA2, CH2OH, CH2OA, CH2NH2, CH2NHA, CH2NA2, COOHy/o COOA, Halrepresenta F, CI, Br o I, A representa alquilo de cadena recta o ramificada con 1 a 10 átomos de C y que puede estar sustituido con 1 a 5 átomosde F y/o CI, o cicloalquilo de 3 a 10 átomos de C, m es 2, 3 o 4, y a sus sales.El invento también serefiere a un pro cedimiento para preparar estos compuestos,a las preparaciones farmaceuticas que los contienen y al empleo de los mismos en la elaboracion de medicamentos destinados al tratamiento y la profilaxis delos ataques de pánico, lasdepresiones, la esquizof renia, los comportamientos obsesivos, la discinesia tardía, los trastornos en el aprendizaje, lostrastornos seniles de la memoria, y destinados también a ejercer una influencia positiva sobre los comportamientos ensituaciones de tension y al trata miento ya la lucha contra las secuelas de un infarto cerebral tal como un ataque de apoplejía y las isquemias cerebrales. Los compuestos de formula I son agonistas5-Ht1a potentes e inhiben la reabsorcion de 5-HT.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19730989A DE19730989A1 (de) | 1997-07-18 | 1997-07-18 | Piperazin-Derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR010932A1 true AR010932A1 (es) | 2000-07-12 |
Family
ID=7836208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980103491A AR010932A1 (es) | 1997-07-18 | 1998-07-17 | Derivados de la piperazina, un procedimiento para prepararlos, el empleo de los mismos en la elaboracion de medicamentos, las preparaciones farmaceuticasque los contienen y un procedimiento para elaborar estas preparaciones farmaceuticas. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6251908B1 (es) |
| EP (1) | EP0998474B1 (es) |
| JP (1) | JP2001510193A (es) |
| KR (1) | KR100528684B1 (es) |
| CN (1) | CN1093127C (es) |
| AR (1) | AR010932A1 (es) |
| AT (1) | ATE353326T1 (es) |
| AU (1) | AU731332B2 (es) |
| BR (1) | BR9810607A (es) |
| CA (1) | CA2296687A1 (es) |
| DE (2) | DE19730989A1 (es) |
| ES (1) | ES2281131T3 (es) |
| HU (1) | HUP0002718A3 (es) |
| ID (1) | ID24663A (es) |
| MY (1) | MY132794A (es) |
| NO (1) | NO20000216L (es) |
| PL (1) | PL191078B1 (es) |
| RU (1) | RU2194048C2 (es) |
| SK (1) | SK352000A3 (es) |
| TW (1) | TW425398B (es) |
| UA (1) | UA59407C2 (es) |
| WO (1) | WO1999003855A1 (es) |
| ZA (1) | ZA986390B (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1212320T1 (en) * | 1999-08-23 | 2005-10-31 | Solvay Pharmaceuticals B.V. | Phenylpiperazines as serotonin reuptake inhibitors |
| DE60131675T2 (de) * | 2000-11-14 | 2008-11-20 | Merck Patent Gmbh | Neue verwendung von substanzen mit kombinierten 5-ht1a agonistischen und serotonin reuptake inhibitor-aktivitäten |
| AR032712A1 (es) | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen |
| DE10112151A1 (de) | 2001-03-14 | 2002-09-19 | Merck Patent Gmbh | Substituierte Benzofuran-2-carbonsäureamide |
| EP1408976B3 (en) | 2001-07-20 | 2010-08-25 | Psychogenics Inc. | Treatment for attention-deficit hyperactivity disorder |
| US20030045449A1 (en) * | 2001-08-15 | 2003-03-06 | Pfizer, Inc. | Pharmaceutical combinations for the treatment of neurodegenerative diseases |
| DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
| DE10259244A1 (de) * | 2002-12-17 | 2004-07-01 | Merck Patent Gmbh | N-(Indolethyl-)cycloamin-Verbindungen |
| DE10305739A1 (de) | 2003-02-11 | 2004-08-19 | Merck Patent Gmbh | Benzofuranderivate |
| DE10315285A1 (de) * | 2003-04-04 | 2004-10-14 | Merck Patent Gmbh | Chromenonindole |
| GT200600414A (es) * | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
| US9066903B2 (en) | 2006-02-28 | 2015-06-30 | The United States Of America As Represented By The Department Of Veterans Affairs | Pharmacological treatment of Parkinson's disease |
| US8034951B2 (en) * | 2008-04-17 | 2011-10-11 | Thomas Daly | Biological buffers with wide buffering ranges |
| US8822728B2 (en) | 2008-04-17 | 2014-09-02 | Thomas Daly | Biological buffers with wide buffering ranges |
| US7635791B2 (en) * | 2008-04-17 | 2009-12-22 | Tpat Ip Llc | Biological buffers with wide buffering ranges |
| US9090638B2 (en) | 2008-04-17 | 2015-07-28 | Thomas Daly | Biological buffers with wide buffering ranges |
| US8334402B2 (en) * | 2008-04-17 | 2012-12-18 | Thomas Daly | Biological buffers with wide buffering ranges |
| US7939659B2 (en) * | 2008-04-17 | 2011-05-10 | Thomas Daly | Biological buffers with wide buffering ranges |
| US9447310B2 (en) | 2008-04-17 | 2016-09-20 | Thomas P. Daly | Biological buffers with wide buffering ranges |
| US20170313920A1 (en) | 2010-10-06 | 2017-11-02 | Thomas P. Daly | Biological Buffers with Wide Buffering Ranges |
| US8519141B2 (en) | 2008-04-17 | 2013-08-27 | Thomas Daly | Biological buffers with wide buffering ranges |
| CA2725356C (en) * | 2008-05-30 | 2018-10-16 | Psychogenics, Inc. | Use of eltoprazine for improving symptoms of cognitive impairment associated with non-adhd neurological and mental disorders |
| RU2560976C2 (ru) | 2009-05-12 | 2015-08-20 | Трансген Са | Способ продуцирования и очистки ортопоксвируса |
| CN102206214B (zh) * | 2011-04-07 | 2014-03-12 | 华中科技大学 | 苯并吡喃酮类衍生物及其应用 |
| US9475754B2 (en) | 2011-10-06 | 2016-10-25 | Thomas P. Daly | Biological buffers with wide buffering ranges |
| AU2013265288B2 (en) * | 2012-05-23 | 2017-12-21 | Nerviano Medical Sciences S.R.L. | Process for the preparation of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide |
| EP3027607B1 (en) | 2013-07-29 | 2020-08-26 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compounds and methods of use thereof |
| CN105418506B (zh) * | 2014-09-19 | 2018-04-24 | 上海医药工业研究院 | 乙酰苄胺哌嗪类衍生物及其作为脑神经保护剂的应用 |
| US10316025B2 (en) | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB146691A (en) * | 1919-05-29 | 1920-07-15 | William Herbert Tripp | Apparatus for indicating and recording side drift or leeway of aircraft |
| FR2189027B1 (es) * | 1972-06-21 | 1976-03-05 | Leurquin Laboratoires Fr | |
| DE4333254A1 (de) * | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
| ATE242230T1 (de) * | 1996-07-26 | 2003-06-15 | Nissan Chemical Ind Ltd | Chroman derivate |
| CA2297825C (en) * | 1997-07-25 | 2006-03-14 | H. Lundbeck A/S | Indole and 2,3-dihydroindole derivatives, their preparation and use |
-
1997
- 1997-07-18 DE DE19730989A patent/DE19730989A1/de not_active Withdrawn
-
1998
- 1998-06-29 AT AT98938671T patent/ATE353326T1/de not_active IP Right Cessation
- 1998-06-29 JP JP2000503079A patent/JP2001510193A/ja active Pending
- 1998-06-29 BR BR9810607-4A patent/BR9810607A/pt not_active Application Discontinuation
- 1998-06-29 RU RU2000102920/04A patent/RU2194048C2/ru not_active IP Right Cessation
- 1998-06-29 ES ES98938671T patent/ES2281131T3/es not_active Expired - Lifetime
- 1998-06-29 PL PL338075A patent/PL191078B1/pl not_active IP Right Cessation
- 1998-06-29 US US09/462,468 patent/US6251908B1/en not_active Expired - Fee Related
- 1998-06-29 UA UA2000020920A patent/UA59407C2/uk unknown
- 1998-06-29 WO PCT/EP1998/003956 patent/WO1999003855A1/de not_active Application Discontinuation
- 1998-06-29 AU AU87302/98A patent/AU731332B2/en not_active Ceased
- 1998-06-29 CA CA002296687A patent/CA2296687A1/en not_active Abandoned
- 1998-06-29 EP EP98938671A patent/EP0998474B1/de not_active Expired - Lifetime
- 1998-06-29 DE DE59813899T patent/DE59813899D1/de not_active Expired - Fee Related
- 1998-06-29 KR KR10-2000-7000522A patent/KR100528684B1/ko not_active IP Right Cessation
- 1998-06-29 HU HU0002718A patent/HUP0002718A3/hu unknown
- 1998-06-29 SK SK35-2000A patent/SK352000A3/sk unknown
- 1998-06-29 ID IDW20000151A patent/ID24663A/id unknown
- 1998-06-29 CN CN98807377A patent/CN1093127C/zh not_active Expired - Fee Related
- 1998-07-16 MY MYPI98003262A patent/MY132794A/en unknown
- 1998-07-17 TW TW087111694A patent/TW425398B/zh not_active IP Right Cessation
- 1998-07-17 AR ARP980103491A patent/AR010932A1/es unknown
- 1998-07-17 ZA ZA986390A patent/ZA986390B/xx unknown
-
2000
- 2000-01-17 NO NO20000216A patent/NO20000216L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2194048C2 (ru) | 2002-12-10 |
| US6251908B1 (en) | 2001-06-26 |
| PL338075A1 (en) | 2000-09-25 |
| AU731332B2 (en) | 2001-03-29 |
| CN1264379A (zh) | 2000-08-23 |
| EP0998474A1 (de) | 2000-05-10 |
| WO1999003855A1 (de) | 1999-01-28 |
| DE59813899D1 (de) | 2007-03-22 |
| ES2281131T3 (es) | 2007-09-16 |
| BR9810607A (pt) | 2000-07-11 |
| AU8730298A (en) | 1999-02-10 |
| KR20010021957A (ko) | 2001-03-15 |
| NO20000216D0 (no) | 2000-01-17 |
| PL191078B1 (pl) | 2006-03-31 |
| KR100528684B1 (ko) | 2005-11-15 |
| SK352000A3 (en) | 2000-06-12 |
| ATE353326T1 (de) | 2007-02-15 |
| UA59407C2 (uk) | 2003-09-15 |
| CN1093127C (zh) | 2002-10-23 |
| MY132794A (en) | 2007-10-31 |
| ID24663A (id) | 2000-07-27 |
| JP2001510193A (ja) | 2001-07-31 |
| HUP0002718A3 (en) | 2001-11-28 |
| ZA986390B (en) | 1999-05-24 |
| TW425398B (en) | 2001-03-11 |
| DE19730989A1 (de) | 1999-01-21 |
| CA2296687A1 (en) | 1999-01-28 |
| EP0998474B1 (de) | 2007-02-07 |
| HUP0002718A2 (hu) | 2001-10-28 |
| NO20000216L (no) | 2000-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR010932A1 (es) | Derivados de la piperazina, un procedimiento para prepararlos, el empleo de los mismos en la elaboracion de medicamentos, las preparaciones farmaceuticasque los contienen y un procedimiento para elaborar estas preparaciones farmaceuticas. | |
| AR088808A2 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
| PA8577101A1 (es) | Nuevos derivados de glicosido de tiofeno, procedimientos para la preparacion de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
| ES2063093T3 (es) | Composiciones orales. | |
| AR057035A1 (es) | SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS | |
| AR058348A1 (es) | Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden | |
| PA8591301A1 (es) | Sales de aluminio de alta eficacia y baja irritacion y productos relacionados | |
| ECSP055582A (es) | Derivados de benzotiazol que tienen actividad agonista de beta-2-adrenorreceptor | |
| PA8452201A1 (es) | Derivados de 9-desoxo-9a-aza-9a -homoeritromicina a c-4"sustituidos. | |
| CR7576A (es) | Nuevas sales de perindopril y composiciones farmaceuticas que las contienen | |
| MX9307232A (es) | Arilcicloalquilaminas n,n-disustituidas, sus sales, medicamentos que contiene estos compuestos y su empleo, asi como procedimientos para su preparacion. | |
| BR9510010A (pt) | Processo para a preparação de uma composição aquosa para o cuidado oral contendo um composto liberador de ion estanoso | |
| AR016134A1 (es) | Compuestos derivados de propil-amida o butil-indanilo, composicion farmaceutica que los contiene y su uso para la fabricacion de un medicamento con metalo-proteinasas inhibidoras de la agrecanasa y matriz extracelular eficaz en el tratamiento de la artritis | |
| UY26070A1 (es) | Derivados de resorcinol | |
| MX9304820A (es) | Derivados de 1, 4-benzodioxano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| DE50106211D1 (de) | Mittel zur adjuvanten therapie von demenzen enthaltend alpha-liponsäure | |
| AR002273A1 (es) | Derivados de la 4-amino-benzoilguanidina, un procedimiento para prepararlos, el empleo de los mismos para preparar un medicamento, laspreparaciones farmaceuticas que las contienen y un procedimiento para preparar estas preparaciones farmaceuticas. | |
| ES2189736T3 (es) | Derivados de la benzamida y medicamentos que los contienen. | |
| PT937043E (pt) | Novos derivados tetra-hidropiridinicos substituidos processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| ES2086442T3 (es) | Derivados de fluoroetilcamptotecina. | |
| AR003093A1 (es) | Nuevos derivados de imidazol-n-bencildioxol, su procedimiento de preparacion, su aplicacion a titulo de medicamentos, composicionesfarmaceuticas y nueva utilizacion. | |
| MX170421B (es) | Mejoras a composicion oral antibacterial | |
| AR127561A1 (es) | Compuestos para el tratamiento de trastornos dependientes de cinasas | |
| AR052167A1 (es) | Proceso e intermediarios para la preparacion de canfosfamida y sus sales, composiciones farmaceuticas que contienen algunos intermediarios, y su uso como agentes anticancer | |
| AR004680A1 (es) | Derivados de la alquenil-benzoilguanidina, procedimiento para prepararlos y preparaciones farmaceuticas que los contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |